Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
American Journal of Physiology. Endocrinology and Metabolism|May 13, 2020
Lower oxygen consumption and Complex I activity in mitochondria isolated from skeletal muscle of fetal sheep with intrauterine growth restrictionAlexander L Pendleton, Andrew T Antolic, Amy C Kelly, et al.Antimicrobial Agents and Chemotherapy|September 1, 1995
Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanolV Nair, M H St Clair, J E Reardon, et al.Translational Animal Science|November 16, 2020
Relationship between live body condition score and carcass fat measures in equineLance A Baker, Amanda M Burrows, Kelsey J Nonella, et al.Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Long-read assembly of a Great Dane genome highlights the contribution of GC-rich sequence and mobile elements to canine genomesJulia V Halo, Amanda L Pendleton, Feichen Shen, et al.Scientific Reports|July 23, 2020
Conservation of Cdc14 phosphatase specificity in plant fungal pathogens: implications for antifungal developmentAndrew G DeMarco, Kedric L Milholland, Amanda L Pendleton, et al.Antiviral Therapy|August 9, 2001
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experienceR T Schooley, N Clumeck, R Haubrich, et al.Antimicrobial Agents and Chemotherapy|May 1, 1997
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activityS M Daluge, S S Good, M B Faletto, et al.Nature Communications|July 19, 2017
Ancient European dog genomes reveal continuity since the Early NeolithicLaura R Botigué, Shiya Song, Amelie Scheu, et al.Antimicrobial Agents and Chemotherapy|December 22, 1999
Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studiesJ M Barnett, A Cadman, D Gor, et al.Journal of Medicinal Chemistry|February 12, 2015
Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cellsAlexander V Aksenov, Alexander N Smirnov, Igor V Magedov, et al.Pageof 13